Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 April 2024 | Story Anthony Mthembu | Photo Francois van Vuuren
Varsity Cup 2024
The FNB UFS Shimlas are the winners of the 2024 FNB Varsity Cup.

The FNB UFS Shimlas are the winners of the 2024 FNB Varsity Cup. This comes after a 45-42 victory over the FNB UCT Ikeys in the final, which took place on 21 April 2024 at Shimla Park. “It was one of the best matches I have been involved in as a coach; both teams played unbelievable rugby and we are just so pleased to get this great result,” said Andre Tredoux, Head Coach of the FNB UFS Shimlas.

The last time the Shimlas won the title was in 2015. As such, Tredoux indicates that the team is thankful to bring the trophy home. Prof Francis Petersen – Vice-Chancellor and Principal of the University of the Free State (UFS) – was also in attendance at the final.  In his congratulatory message, Prof Petersen described the match as a fantastic scene. “The team represented the University of the Free State; they represented one of our key values, which is excellence, but they also showed that sport – in this case rugby – has a social cohesion value,” he said.

The battle for the championship

Tredoux indicates that the match was a tough one, especially when the score stood at 14-0 and 31-19 against the Shimlas. He says the team had to dig deep to find its footing in the game again, considering that they were behind so early in the game. As such, he highlights, “It was a huge effort to get back into the game and keep playing as a team. We really focused on staying in the fight and being connected, as we knew Ikeys would tire in the later stage of the game.”

Subsequent to this monumental victory, he describes the team as having the ‘hearts of champions’ and credits their love and enthusiasm for the game as part of the reason for their success. In fact, one person who exemplifies this is the Shimla scrumhalf Jandre Nel, who was named the FNB Player that Rocks.

Furthermore, Tredoux thanks the UFS community for showing up in their numbers at the game. He also commends his team for working towards this victory, including “Inus Keyser, Mark Nichols, and Edith Maritz – our physiotherapist – for keeping the team healthy, as well as assistant coaches Melusi Mthethwa and Tiaan Liebenberg, and Jerry Laka, Director of Kovsie Sport at the UFS”.

Watch the highlights below:

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept